Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer-Reference-Cited by-同舟云学术

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

Published:2021-01-01 Issue:1 Volume:10 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Boesch Maximilian¹^ORCID,Baty Florent¹^ORCID,Albrich Werner C.²,Flatz Lukas³⁴^ORCID,Rodriguez Regulo⁵,Rothschild Sacha I.⁶^ORCID,Joerger Markus⁷,Früh Martin⁷⁸,Brutsche Martin H.¹^ORCID

Affiliation:

1. Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

2. Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

3. Center for Dermatooncology, Department of Dermatology, Eberhard Karls University Tübingen, Tübingen, Germany

4. Institute of Immunobiology, Cantonal Hospital St.Gallen, St.Gallen, Switzerland

5. Institute of Pathology, Cantonal Hospital St.Gallen, St.Gallen, Switzerland

6. Department of Medical Oncology and Comprehensive Cancer Center, University Hospital of Basel, Basel, Switzerland

7. Department of Medical Oncology and Hematology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

8. Department of Medical Oncology, University Hospital Bern, Bern, Switzerland

Funder

Lungenliga St. Gallen-Appenzell

Stiftung Propter Homines

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2021.1988403

Reference56 articles.

1. Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

2. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

3. The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics

4. High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut-derived immune cells and the gut-lung axis in ARDS;Critical Care;2024-07-04

2. What is disease modification and is this concept even helpful?;European Journal of Internal Medicine;2024-06

3. Lung Microbiome in Lung Cancer: A New Horizon in Cancer Study;Cancer Prevention Research;2024-05-24

4. Circulating microbiome DNA as biomarkers for early diagnosis and recurrence of lung cancer;Cell Reports Medicine;2024-04

5. Intratumor microbiome-derived butyrate promotes lung cancer metastasis;Cell Reports Medicine;2024-04